Shares of Nutex Health Inc. (NASDAQ: NUTX) are soaring 11.17% in pre-market trading on Wednesday, building on the previous day's 9.37% gain. The surge comes in response to the company's release of its outstanding first-quarter 2025 financial results, which demonstrated remarkable growth and profitability across key metrics.

The healthcare management and operations company reported several impressive achievements for Q1 2025: - Total revenue surged 213.8% year-over-year to $211.8 million - Net income attributable to Nutex Health reached $14.6 million, a significant turnaround from a $0.4 million loss in Q1 2024 - Diluted earnings per share (EPS) jumped to $2.56, compared to a loss of $(0.08) per share in the same period last year - EBITDA increased by 507.0% to $43.1 million - Adjusted EBITDA rose to $72.8 million, up from a $0.4 million loss in Q1 2024

The company's stellar performance can be attributed to successful arbitration efforts resulting in fairer payments and increased patient visits. Nutex Health's Hospital Division saw a 20.5% growth in total visits, reaching 48,269 for the quarter. Additionally, the company reported strong cash flow, with net cash from operating activities of $51.0 million. As of March 31, 2025, Nutex Health maintained a solid financial position with total assets of $761.9 million, including $87.7 million in cash and cash equivalents, while long-term debt remained manageable at $21.7 million. The company's improved financial health and operational efficiency have clearly resonated with investors, driving the significant stock price increase in both after-hours trading on Tuesday and pre-market trading on Wednesday.